What’s the current market cap for Nature's Sunshine Products stock?

Nature's Sunshine Products (NATR) has a market cap of $385M as of May 27, 2026.

What is the P/E ratio for Nature's Sunshine Products stock?

The price to earnings (P/E) ratio for Nature's Sunshine Products (NATR) stock is 19.9 as of May 27, 2026.

Does Nature's Sunshine Products stock pay dividends?

No, Nature's Sunshine Products (NATR) stock does not pay dividends to its shareholders as of May 27, 2026.

When is the next Nature's Sunshine Products dividend payment date?

Nature's Sunshine Products (NATR) stock does not pay dividends to its shareholders.

What is the beta indicator for Nature's Sunshine Products?

Nature's Sunshine Products (NATR) has a beta rating of 0.95. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Nature's Sunshine Products stock | $NATR Share Price

13:30

15:10

16:45

18:25

20:00

About Nature's Sunshine Products

Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.

Ticker

$NATR

Sector

Consumer Essentials

Primary listing

NASDAQ

Employees

806

Headquarters

Lehi, United States

Website

www.naturessunshine.com

NATR Metrics

BasicAdvanced

$385m

19.90

$1.10

0.95

What the Analysts think about NATR

Analyst ratings (Buy, Hold, Sell) for Nature's Sunshine Products stock.

Bulls say / Bears say

Direct seller of herbal supplements Nature’s Sunshine Products reported Q3 net sales of $128.3 million, a 12% increase year-on-year and above analyst expectations, showing sustained revenue growth (Reuters)

The company raised its full-year 2025 net sales outlook to $476 million–$480 million and increased adjusted EBITDA guidance to $47 million–$49 million, reflecting management’s confidence in ongoing growth (Reuters)

Strategic investments in North American digital channels drove a 52% jump in digital sales in Q3, supporting stronger customer acquisition and retention (Reuters)

Shares of Nature’s Sunshine Products fell as much as 9.8% after a secondary offering of 2.9 million shares was priced at $12 per share, a 19% discount to the previous close, highlighting dilution risk and downward pressure on the stock (Reuters)

Fosun Pharma USA, NATR’s largest shareholder with a 15.5% stake, sold its entire 2.9 million-share block in the secondary offering, which could signal reduced confidence in the company’s near-term outlook (Reuters)

Following the offering, NATR shares were up just 1.2% year-to-date as of the last close, reflecting limited investor enthusiasm despite recent improvements in operations (Reuters)

Data summarised monthly by Lightyear AI. Last updated on 28 Apr 2026.

NATR Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

NATR Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NATR

Capital at risk

Market open

Upcoming events

No upcoming events

Bulls say / Bears say

Strategic investments in North American digital channels drove a 52% jump in digital sales in Q3, supporting stronger customer acquisition and retention (Reuters)

Following the offering, NATR shares were up just 1.2% year-to-date as of the last close, reflecting limited investor enthusiasm despite recent improvements in operations (Reuters)

Data summarised monthly by Lightyear AI. Last updated on 28 Apr 2026.